Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Ganji, Vijay ^a   Kafai, Mohammad R ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Age; methylmalonic acid; NHANES; population attributable risk; population attributable risk percentage

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; METHYLMALONIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METHYLMALONIC ACIDEMIA; NEGRO; SCHOOL CHILD; UNITED STATES; VITAMIN BLOOD LEVEL;

EID: 84855577749     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-2     Document Type: Article

References (60)

1. Neurodegeneration and chronic renal failure in methylmalonic aciduria-a pathophysiological approach. Morath MA, Okun JG, Muller LB, Sauer SW, Horster F, Hoffmannn GF, Kolker S, J Inherit Metab Dis 2008 31 35 43 10.1007/s10545-007- 0571-5 17846917 (Pubitemid 351384881)
2. Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Levin J, Botzel K, Giese A, Vogeer M, Lorenzl S, Dement Geriatr Cogn Disord 2010 29 553 559 10.1159/000314841 20606437
3. Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. Okun JG, Hörster F, Farkas LM, Feyh P, Hinz A, Sauer S, Hoffmann GF, Unsicker K, Mayatepek E, Kölker S, J Biol Chem 2002 277 14674 14680 11847233 (Pubitemid 34952536)
4. Neurological dysfunction in methylmalonic acidemia is probably related to the inhibitory effect of methylmalonate on brain energy production. Wajner M, Coelho JC, J Inherit Metab Dis 1997 20 761 768 10.1023/A:1005359416197 9427143 (Pubitemid 27501011)
5. Low vitamin B-12 status and risk of cognitive decline in older adults. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, Molloy A, Evans JG, Am J Clin Nutr 2007 86 1384 1391 17991650 (Pubitemid 350126242)
6. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Tangney CC, Tang Y, Evans DA, Morris MC, Neurology 2009 72 361 367 10.1212/01.wnl.0000341272.48617.b0 19171834
7. Update on cobalamin, folate, and homocysteine. Carmel R, Green R, Rosenblatt DS, Watkins D, Hematol 2003 2003 62 81 10.1182/asheducation-2003.1.62
8. Homocysteine and methylmalonic acid in diagnosis and Risk assessment from infancy to adolescence. Monsen ALB, Ueland PM, Am J Clin Nutr 2003 78 7 21 12816766 (Pubitemid 39655243)
9. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B-12 and folate. Klee GG, Clin Chem 2000 46 1277 1283 10926922 (Pubitemid 30643299)
10. Prevalence of cobalamin deficiency in the Framingham elderly population. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler S, Allen RH, Am J Clin Nutr 1994 60 2 11 8017332
11. Metabolic abnormalities in cobalamin (vitamin B-12) and folate deficiency. Allen RH, Stabler SP, Savage DG, Lindenbaum J, FASEB J 1993 7 1344 1353 7901104 (Pubitemid 23336162)
12. Cobalamin: a critical vitamin in the elderly. Wolters M, Strohle A, Hahn A, Prev Med 2004 39 1256 1266 10.1016/j.ypmed.2004.04.047 15539065 (Pubitemid 39480670)
13. Food Standards: amendment of standards of identify for enriched products to require addition of folic acid. Food and Drug Administration, Federal Register 1996 61 8781 8797
14. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Center for Disease Control and Prevention, Morb Mortal Wky Rep 1992 41
15. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY, J Am Med Assoc 2001 285 2981 2986 10.1001/jama.285.23.2981 (Pubitemid 32550116)
16. Spina bifida and anencephaly prevalence - United States, 1991-2001. Mathews TJ, Honein MA, Erickson JD, Morb Mortal Wkly Rep 2002 51 9 11
17. Trends in serum folate, red blood cell folate, and circulating total homocysteine concentrations in the US: analysis of data from the National Health and Nutrition Examination Surveys, 1988-2002. Ganji V, Kafai MR, J Nutr 2006 136 153 158 16365075 (Pubitemid 43156501)
18. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH, New Eng J Med 1999 340 1449 1454 10.1056/NEJM199905133401901 10320382 (Pubitemid 29220543)
19. Trends in serum folate after food fortification. Lawrence JM, Petitti DB, Watkins M, Umekubo MA, Lancet 1999 354 9182 915 916 10.1016/S0140-6736(99) 03227-4 10489953 (Pubitemid 29424024)
20. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J, J Nutr 2001 131 3277 3280 11739880 (Pubitemid 33136149)
21. Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid. Ganji V, Kafai MR, Am J Clin Nutr 2006 84 989 994 17093148 (Pubitemid 44730366)
22. Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in the post-folic acid fortification period than in the pre-folic acid fortification period in US adults. Ganji V, Kafai MR, Am J Clin Nutr 2009 89 363 371 19056553
23. Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post-folic acid fortification period than in pre-folic acid fortification period. Wyckoff KF, Ganji V, Am J Clin Nutr 2007 86 1187 1192 17921401 (Pubitemid 47538326)
24. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Morris MS, Jacques PF, Rosenberg IH, Selhub J, Am J Clin Nutr 2007 85 193 200 17209196 (Pubitemid 46067634)
25. Persistence of vitamin B-12 insufficiency among elderly women after folic acid food fortification. Ray JG, Vermeulen MJ, Langman LJ, Boss SG, Cole DE, Clin Biochem 2003 36 387 391 10.1016/S0009-9120(03)00061-4 12849871 (Pubitemid 36776808)
26. Case for folic acid and vitamin B-12 fortification in Europe. Czernichow S, Noisette N, Blacher J, Galan P, Mennen L, Hercberg S, Ducimetière P, Semin Vasc Med 2002 5 156 162
27. Modeling the level of fortification and post-fortification assessments: US experience. Yetley EA, Rader JI, Nutr Rev 2004 62 50 59 15298449
28. Benefits and risks of folic acid to the nervous system. Reynolds EH, J Neurol Neurosurg Psychiatry 2002 72 567 571 10.1136/jnnp.72.5.567 11971038 (Pubitemid 34462806)
29. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic acid induced exacerbation of subacute combined degeneration in pernicious anemia. Scott JM, Weir DG, Lancet 1981 2 8242 337 340 6115113 (Pubitemid 11040583)
30. In vitamin B-12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Selhub J, Morris MS, Jacques PF, Proc Natl Acad Sci USA 2007 104 19995 20000 10.1073/pnas.0709487104 18056804
31. Elevated serum methylmalonic acid concentrations are common among elderly Americans. Morris MS, Jacques PF, Rosenberg IH, Selhub J, J Nutr 2002 132 2799 2803 12221248 (Pubitemid 35013273)
32. Racial differences in prevalence of cobalamin and folate deficiencies in disabled Elderly women. Stabler SP, Allen RH, Fried LP, Pahor M, Kittner SJ, Penninx BW, Guralnik JM, Am J Clin Nutr 1999 70 911 919 10539754 (Pubitemid 29512919)
33. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C, Am J Clin Nutr 1999 70 904 910 10539753 (Pubitemid 29512918)
34. Biochemical indicators Of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ, Am J Clin Nutr 2005 82 442 450 16087991
35. National Health and Nutrition ExaminationSurvey, 1999-2000. Public use data files. National Center for Health Statistics, http://www.cdc.gov/nchs/ nhanes/nhanes1999-2000/lab99-00.htm Center for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/NHANES99-00.htm. Accessed on 05/15/2008
36. National Health and Nutrition Examination Survey, 2001-2002. Public use data files. National Center for Health Statistics, http://www.cdc.gov/nchs/ nhanes/nhanes2001-2002/lab01-02.htm Center for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/NHANES01-02.htm. Accessed on 05/16/2008
37. National Health and Nutrition Examination Survey, 2003-2004. Public use data files. National Center for Health Statistics, http://www.cdc.gov/nchs/ nhanes/nhanes2001-2002/lab03-04.htm Center for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/NHANES01-02.htm. Accessed on 05/17/2008
38. National Health and Nutrition Examination Survey,1999-2000. Survey operations manuals, brochures, consent documents. March 2001. National Center for Health Statistics, http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/current- nhanes-99-00.htm Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/nhanes99-00.htm. Accessed on 05/19/2008
39. National Health and Nutrition Examination Survey, 2001-2002. Survey operations manuals, brochures, consent documents March 2001. National Center for Health Statistics, http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/current- nhanes-01-02.htm Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/current-nhanes-01-02.htm. Accessed on 5/19/2008
40. National Health and Nutrition ExaminationSurvey, 2003-2004. Survey operations manuals, brochures, consent documents March 2001. National Center for Health Statistics, http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/current- nhanes-03-04.htm Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/current-nhanes-03-04. htm Accessed on 05/192008
41. National Health and Nutrition Examination Survey, 2003-2004. Laboratory Methods, 1999-2000. National Center for Health Statistics, http://www.cdc.gov/ nchs/nhanes/nhanes1999-2000/lab-methods-99-00.htm Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/lab- methods99-00.htm. Accessed on 05/25/2008
42. National Health and Nutrition Examination Survey, 2003-2004. Laboratory Methods, 2001-2002. National Center for Health Statistics, http://www.cdc.gov/ nchs/nhanes/nhanes2001-2002/lab01-02.htm Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/lab-methods01- 02.htm. Accessed on 05/252008
43. National Health and Nutrition Examination Survey, 2003-2004. Laboratory Methods, 2003-2004. National Center for Health Statistics, Centers for Disease Control and Prevention Home Page: http://www.cdc.gov/nchs/about/major/nhanes/ lab-methods03-04.htm. Accessed on 05/25/2008
44. Screening for vitamin B-12 and folate deficiency in older persons. Clarke R, Refsum H, Birks J, Evans JG, Johnston C, Sherliker P, Ueland PM, Schneede J, McPartlin J, Nexo E, Scott JM, Am J Clin Nutr 2003 77 1241 1247 12716678 (Pubitemid 44858442)
45. A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial. Hotu C, Bagg W, Collins J, Harwood L, Whalley G, Doughty R, Gamble G, Braatvedt G, Nephrol Dial Transplant 2010 25 3260 3266 10.1093/ndt/gfq168 20375028
46. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Morris MS, Jacques PF, Rosenberg IH, Selhub J, Am J Clin Nutr 2010 91 1733 1744 10.3945/ajcn.2009.28671 20357042
47. Epidemiology in Medicine. Hennckens CH, Buring JE, Boston, MA: Little Brown Co 1987
48. Use and misuse of population attributable fractions. Rockhill B, Newman B, Weinberg C, Am J Public Health 1998 88 15 19 10.2105/AJPH.88.1.15 9584027
49. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Horster F, Baumgartner MR, Viardot C, Suormala T, Burgard P, Fowler B, Hoffmann GF, Garbade SF, Kölker S, Baumgartner ER, Pediatr Res 2007 62 225 230 10.1203/PDR.0b013e3180a0325f 17597648 (Pubitemid 47205728)
50. Sources of propionate in inborn errors of propionate metabolism. Thompson GN, Walter JH, Bresson JL, Ford GC, Lyonnet SL, Chalmers RA, Saudubray JM, Leonard JV, Halliday D, Metabolism 1990 39 1133 1137 10.1016/0026-0495(90)90084- P 2233273 (Pubitemid 20376342)
51. Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F, Am J Clin Nutr 2005 82 636 643 16155278
52. Plasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring Study. Tucker KL, Rich S, Rosenberg IH, Jacques P, Dallal G, Wilson WF, Selhub J, Am J Clin Nutr 2000 71 514 522 10648266 (Pubitemid 30061231)
53. Cobalamin, the stomach, and aging. Carmel R, Am J Clin Nutr 1997 66 750 759 9322548 (Pubitemid 27415557)
54. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. van Asselt DZ, de Groot LC, van Staveren WA, Blom HJ, Wevers RA, Biemond I, Hoefnagels WH, Am J Clin Nutr 1998 68 328 334 9701190 (Pubitemid 28355650)
55. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B-12 absorption. Saltzman JR, Kemp JA, Golner BB, Pedrosa MC, Dallal GE, Russell RM, J Am Coll Nutr 1994 13 584 591 7706591 (Pubitemid 24375357)
56. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Presotto F, Sabini B, Cecchetto A, Plebani M, De Lazzari F, Pedini B, Betterle C, Helicobacter 2003 8 578 584 10.1111/j.1523-5378.2003.00187.x 14632671 (Pubitemid 37553430)
57. Total homocysteine, vitamin B-12, and total antioxidant status in vegetarians. Herrmann W, Schorr H, Purschwitz K, Rassoul F, Richter V, Clin Chem 2001 47 1094 1101 11375297 (Pubitemid 32493597)
58. RIA for serum holo-transcobalamin: method evaluation in the clinical laboratory and reference interval. Loikas S, Lopponen M, Suominen P, Moller J, Irjala K, Isoaho R, Kivela SL, Koskinen P, Pelliniemi TT, Clin Chem 2003 49 455 462 10.1373/49.3.455 12600958 (Pubitemid 36250206)
59. Holotranscobalamin-a first choice assay for diagnosing early vitamin B-12 deficiency. Havas AM, Nexo E, J Intern Med 2005 257 289 298 10.1111/j.1365-2796.2004.01437.x 15715686 (Pubitemid 40342132)
60. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Herrmann W, Obeid R, Schorr H, Geisel J, Clin Chem Lab Med 2003 41 1478 1488 10.1515/CCLM.2003.227 14656029 (Pubitemid 37493564)